Arecor Therapeutics (AREC) RNS Announcements

Add to Alert list
Date Time Source Announcement
27 Jun 2023 07:00 AM
RNS
Arecor granted key patents in Europe and China
26 Jun 2023 07:00 AM
RNS
Arecor presents positive data for AT247 at ADA
09 Jun 2023 03:35 PM
RNS
Exercise of rollover options & Total Voting Rights
09 Jun 2023 03:35 PM
RNS
Exercise of rollover options & Total Voting Rights
09 Jun 2023 12:43 PM
RNS
Result of AGM
09 Jun 2023 07:00 AM
RNS
AGM Statement
24 May 2023 07:00 AM
RNS
Director/PDMR Shareholding
15 May 2023 07:00 AM
RNS
TETRIS PHARMA LAUNCHES OGLUO® IN DENMARK & NORWAY
04 May 2023 04:00 PM
RNS
ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM
26 Apr 2023 07:00 AM
RNS
Arecor Granted Key U.S Patent
21 Apr 2023 07:00 AM
RNS
Arecor on Investor Meet Company Platform
21 Apr 2023 07:00 AM
RNS
Arecor on Investor Meet Company Platform
20 Apr 2023 07:00 AM
RNS
Unaudited Preliminary Results for 2022
05 Apr 2023 07:00 AM
RNS
Arecor Appoints Chief Business Officer
22 Mar 2023 07:00 AM
RNS
FIRST PATIENT DOSED IN AT278 CLINICAL TRIAL
13 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
13 Mar 2023 02:05 PM
RNS
Second Price Monitoring Extn
13 Mar 2023 02:00 PM
RNS
Price Monitoring Extension
13 Mar 2023 11:05 AM
RNS
Second Price Monitoring Extn
13 Mar 2023 11:00 AM
RNS
Price Monitoring Extension
13 Mar 2023 09:05 AM
RNS
Second Price Monitoring Extn
13 Mar 2023 09:00 AM
RNS
Price Monitoring Extension
01 Mar 2023 07:00 AM
RNS
ARECOR TO PRESENT SHARESOC WEBINAR
24 Feb 2023 04:44 PM
RNS
Holding(s) in Company
24 Feb 2023 07:00 AM
RNS
Notice of Results
16 Feb 2023 07:00 AM
RNS
Arecor Granted Patents in India and the US
14 Feb 2023 07:01 AM
RNS
ARECOR STRENGTHENS COLLABORATION WITH PARTNER
30 Jan 2023 07:00 AM
RNS
Arecor Publishes Data for AT278 in Diabetes Care
19 Jan 2023 07:00 AM
RNS
BUSINESS UPDATE
12 Jan 2023 07:00 AM
RNS
ARECOR ANNOUNCES TRANSFER OF AT307 TO HIKMA
04 Jan 2023 07:00 AM
RNS
TETRIS PHARMA LAUNCHES OGLUO® IN AUSTRIA
12 Dec 2022 10:04 AM
RNS
TETRIS PHARMA SERVICE AGREEMENT WITH SYNEOS HEALTH
06 Dec 2022 04:03 PM
RNS
Grant of LTIP Options and PDMR Dealing
22 Nov 2022 07:00 AM
RNS
ARECOR TO COMMENCE SECOND TRIAL WITH AT278
22 Nov 2022 07:00 AM
RNS
ARECOGRANTED PATENT IN JAPAN AND SOUTH KOREA
17 Nov 2022 07:00 AM
RNS
Grant of AESOP Options and PDMR Dealing
15 Nov 2022 12:43 PM
EQS
Arecor Therapeutics scientist hopeful that arti...
10 Nov 2022 07:00 AM
RNS
SPECIALTY HOSPITAL FORMULATION COLLABORATION
08 Nov 2022 07:00 AM
RNS
Exercise of options and PDMR dealing
01 Nov 2022 07:00 AM
RNS
TETRIS PHARMA LAUNCHES OGLUO® IN GERMANY
11 Oct 2022 07:00 AM
RNS
Headline results from Phase I trial of AT247
20 Sep 2022 11:03 AM
RNS
Arecor Presents Positive Data for AT278 at EASD
08 Sep 2022 07:00 AM
RNS
Interim Results for six months ended 30 June 2022
17 Aug 2022 07:00 AM
RNS
Notice of Interim Results
09 Aug 2022 07:00 AM
RNS
ARECOR GRANTED EUROPEAN PATENTS
05 Aug 2022 03:33 PM
RNS
Holding(s) in Company
05 Aug 2022 11:52 AM
RNS
Holding(s) in Company
04 Aug 2022 02:09 PM
RNS
Holding(s) in Company
04 Aug 2022 02:08 PM
RNS
Holding(s) in Company
04 Aug 2022 10:45 AM
RNS
Holding(s) in Company
UK 100

Latest directors dealings